' New Standard of Care ' for Capecitabine Hand-Foot Syndrome ' New Standard of Care ' for Capecitabine Hand-Foot Syndrome

Topical gel with 1% diclofenac should be the new standard of care to prevent this side effect, say oncologists highlighting what they describe as the best study from the recent ASCO meeting.Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news